K
Koichiro Kurauchi
Researcher at Kagoshima University
Publications - 15
Citations - 202
Koichiro Kurauchi is an academic researcher from Kagoshima University. The author has contributed to research in topics: Hematopoietic stem cell transplantation & Acrolein. The author has an hindex of 7, co-authored 15 publications receiving 149 citations.
Papers
More filters
Journal ArticleDOI
Role of metabolites of cyclophosphamide in cardiotoxicity
TL;DR: By inhibiting ROS generation, increasing ALDH activity and decreasing the presence of acrolein, NAC has the potential to prevent CY-induced cardiotoxicity.
Journal ArticleDOI
Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Leukemia
TL;DR: Although CMV reactivation may reduce the risk of relapse after HSCT for pediatric acute leukemia, effective management of severe acute GVHD and better prophylaxis and treatment of opportunistic infections are required to reduce the incidence of NRM and improve survival.
Journal ArticleDOI
Mechanisms of Fatal Cardiotoxicity following High-Dose Cyclophosphamide Therapy and a Method for Its Prevention.
Takuro Nishikawa,Emiko Miyahara,Koichiro Kurauchi,Erika Watanabe,Kazuro Ikawa,Kousuke Asaba,Takayuki Tanabe,Yasuhiro Okamoto,Yoshifumi Kawano +8 more
TL;DR: Any competitive metabolic processing of CY that reduces its transformation to acrolein is likely to be an important mechanism for preventing cardiotoxicity.
Journal ArticleDOI
Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation
Jiro Inagaki,Hiroshi Moritake,Takuro Nishikawa,Nobuyuki Hyakuna,Masahiko Okada,So-ichi Suenobu,Kozo Nagai,Yuko Honda,Maiko Shimomura,Reiji Fukano,Maiko Noguchi,Koichiro Kurauchi,Shinji Tanioka,Jun Okamura +13 more
TL;DR: Better therapeutic strategies are needed to lower the incidence of severe cGVHD, considering the longer life expectancy of pediatric HSCT survivors.
Journal ArticleDOI
Hematopoietic stem cell transplantation following unsuccessful salvage treatment for relapsed acute lymphoblastic leukemia in children.
TL;DR: This study aimed to investigate the impact of disease status at SCT on the outcomes of SCT for these children, whose prognosis is considered unquestionably poor even with SCT.